Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation - TechCrunch

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation - TechCrunch
Technology

Listen to this article

0%

When de-extinction startup Colossal Biosciences revealed last year that it was attempting to “resurrect” the dire wolf from genetic material found in fossils, we argued that, despite the controversy … [+2300 chars]

Leave A Comment

Comments are moderated and may take time to appear.

Comments

No comments yet. Be the first to comment!

Stay Connected